Unusual Complication of Multidrug Resistant Tuberculosis

Case Reports in Nephrology
Prerna Sharma, Ravindra Nath Sahay

Abstract

Capreomycin is a second-line drug often used for multidrug-resistant tuberculosis which can result in nephrotoxic effects similar to other aminoglycosides. We describe a case of capreomycin induced Bartter-like syndrome with hypocalcemic tetany. 23-year-old female patient presented with carpopedal spasms and tingling sensations in hands. Patient was being treated with capreomycin for two months for tuberculosis. On further investigation, hypocalcemia, hyponatremia, hypomagnesemia, hypokalemia, and hypochloremic metabolic alkalosis were noted. Vitamin D and serum PTH levels were within normal limits. Hypercalciuria was confirmed by urine calcium/creatinine ratio. Calcium, potassium, and magnesium supplementation was given and capreomycin was discontinued. Electrolytes normalized in two days after cessation of capreomycin with no further abnormalities on repeat investigations. Aminoglycosides can result in renal tubular dysfunction leading to Fanconi syndrome, Bartter syndrome, and distal tubular acidosis. Impaired mitochondrial function in the tubular cells has been hypothesized as the possible cause of these tubulopathies. Acquired Bartter-like syndrome phenotypically resembles autosomal dominant type 5 Bartter syndrome. Treatm...Continue Reading

References

Mar 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R W Steiner, A S Omachi
Oct 6, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Chi-Chih HungHung-Chun Chen
Sep 22, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ying-Shou ChenChien-Liang Chen
Nov 4, 2009·Journal of Postgraduate Medicine·A ChrispalV Moses
Apr 20, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Hannsjörg W Seyberth, Karl P Schlingmann
Sep 24, 2011·International Journal of Nephrology·Georges Deschênes, Marc Fila
Dec 26, 2013·QJM : Monthly Journal of the Association of Physicians·A M HallR J Unwin

❮ Previous
Next ❯

Citations

Nov 6, 2020·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Vishrutha Sujith PoojariAkanksha Jaiswal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The Journal of the Association of Physicians of India
Srikant R GadwalkarD V Deepa
© 2022 Meta ULC. All rights reserved